Stay updated on Atezolizumab Subq in NSCLC: Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab Subq in NSCLC: Clinical Trial page.

Latest updates to the Atezolizumab Subq in NSCLC: Clinical Trial page
- Check2 days agoChange DetectedThe page footer revision number was updated from v3.5.2 to v3.5.3, reflecting a site release/version change rather than altering the study details.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was deleted on the site.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision label updated to v3.4.3, replacing the previous v3.4.2 label.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision: v3.4.2 was added, and the previous notices about government funding lapses and NIH operating status were removed. These are administrative site updates and do not change the study details or functionality presented on the page.SummaryDifference0.2%

- Check81 days agoChange DetectedAdded a government funding lapse notice at the top of the page with guidance and links to cc.nih.gov and opm.gov, and updated the revision tag from v3.4.0 to v3.4.1.SummaryDifference0.2%

Stay in the know with updates to Atezolizumab Subq in NSCLC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab Subq in NSCLC: Clinical Trial page.